Position in ALKS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$40,451
+$5,644 QoQ
Shares Held
1,144
-8.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Salomon & Ludwin, LLC holds $386,363 across 20 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
669 | $79,082 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,591 | $47,985 | |
| 3 | GALDY |
Galderma Group AG/ADR
|
1,046 | $40,689 | |
| 4 | ALKS |
Alkermes plc.
This page
|
1,144 | $40,451 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
755 | $39,025 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
301 | $23,146 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
339 | $18,750 | |
| 8 | HLN |
Haleon plc
|
1,786 | $17,877 |
All Filings in ALKS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,451 | 1,144 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $34,807 | 1,244 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $17,310 | 577 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||